CM
Caption Management’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 548 |
|
|
2025
Q1 | – | Sell |
-115,686
| Closed | -$9.79M | – | 568 |
|
|
2024
Q4 | $9.79M | Buy |
115,686
+105,686
| +1,057% | +$8.94M | 0.09% | 16 |
|
|
2024
Q3 | $899K | Buy |
+10,000
| New | +$899K | 0.01% | 185 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 435 |
|
|
2024
Q1 | – | Sell |
-17,600
| Closed | -$1.4M | – | 427 |
|
|
2023
Q4 | $1.4M | Buy |
+17,600
| New | +$1.4M | 0.02% | 126 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 445 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 387 |
|
|
2023
Q1 | – | Sell |
-4,600
| Closed | -$355K | – | 394 |
|
|
2022
Q4 | $355K | Buy |
+4,600
| New | +$355K | 0.01% | 247 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 542 |
|
|
2022
Q2 | – | Sell |
-157,500
| Closed | -$6.52M | – | 522 |
|
|
2022
Q1 | $6.52M | Buy |
157,500
+117,500
| +294% | +$4.86M | 0.08% | 56 |
|
|
2021
Q4 | $1.51M | Sell |
40,000
-29,000
| -42% | -$1.1M | 0.02% | 210 |
|
|
2021
Q3 | $2.27M | Buy |
+69,000
| New | +$2.27M | 0.03% | 148 |
|
|
2020
Q2 | – | Sell |
-25,000
| Closed | -$1.47M | – | 326 |
|
|
2020
Q1 | $1.47M | Sell |
25,000
-63,400
| -72% | -$3.73M | 0.08% | 67 |
|
|
2019
Q4 | $9.14M | Buy |
+88,400
| New | +$9.14M | 0.31% | 7 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 279 |
|
|
2019
Q2 | – | Sell |
-30,000
| Closed | -$427K | – | 255 |
|
|
2019
Q1 | $427K | Buy |
+30,000
| New | +$427K | 0.02% | 128 |
|